These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42. Buggia-Prevot V; Sevalle J; Rossner S; Checler F J Biol Chem; 2008 Apr; 283(15):10037-47. PubMed ID: 18263584 [TBL] [Abstract][Full Text] [Related]
4. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis. Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065 [TBL] [Abstract][Full Text] [Related]
5. Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence. Kimura A; Hata S; Suzuki T J Biol Chem; 2016 Nov; 291(46):24041-24053. PubMed ID: 27687728 [TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. O'Connor T; Sadleir KR; Maus E; Velliquette RA; Zhao J; Cole SL; Eimer WA; Hitt B; Bembinster LA; Lammich S; Lichtenthaler SF; Hébert SS; De Strooper B; Haass C; Bennett DA; Vassar R Neuron; 2008 Dec; 60(6):988-1009. PubMed ID: 19109907 [TBL] [Abstract][Full Text] [Related]
7. Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease. Chen CH; Zhou W; Liu S; Deng Y; Cai F; Tone M; Tone Y; Tong Y; Song W Int J Neuropsychopharmacol; 2012 Feb; 15(1):77-90. PubMed ID: 21329555 [TBL] [Abstract][Full Text] [Related]
8. Beta-site amyloid precursor protein-cleaving enzyme-1 (BACE1)-mediated changes of endogenous amyloid beta in wild-type and transgenic mice in vivo. Hirata-Fukae C; Sidahmed EH; Gooskens TP; Aisen PS; Dewachter I; Devijver H; Van Leuven F; Matsuoka Y Neurosci Lett; 2008 Apr; 435(3):186-9. PubMed ID: 18343582 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes. Ly PT; Wu Y; Zou H; Wang R; Zhou W; Kinoshita A; Zhang M; Yang Y; Cai F; Woodgett J; Song W J Clin Invest; 2013 Jan; 123(1):224-35. PubMed ID: 23202730 [TBL] [Abstract][Full Text] [Related]
10. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models. Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932 [TBL] [Abstract][Full Text] [Related]
11. Palmitate-induced C/EBP homologous protein activation leads to NF-κB-mediated increase in BACE1 activity and amyloid beta genesis. Marwarha G; Schommer J; Lund J; Schommer T; Ghribi O J Neurochem; 2018 Mar; 144(6):761-779. PubMed ID: 29315574 [TBL] [Abstract][Full Text] [Related]
12. Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic. Hook G; Yu J; Toneff T; Kindy M; Hook V J Alzheimers Dis; 2014; 41(1):129-49. PubMed ID: 24595198 [TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rg1 attenuates β-amyloid generation via suppressing PPARγ-regulated BACE1 activity in N2a-APP695 cells. Chen LM; Lin ZY; Zhu YG; Lin N; Zhang J; Pan XD; Chen XC Eur J Pharmacol; 2012 Jan; 675(1-3):15-21. PubMed ID: 22166376 [TBL] [Abstract][Full Text] [Related]
14. BAG-1M co-activates BACE1 transcription through NF-κB and accelerates Aβ production and memory deficit in Alzheimer's disease mouse model. Shi Z; Hong Y; Zhang K; Wang J; Zheng L; Zhang Z; Hu Z; Han X; Han Y; Chen T; Yao Q; Cui H; Hong W Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2398-2407. PubMed ID: 28502705 [TBL] [Abstract][Full Text] [Related]
15. Dimethyl fumarate exerts neuroprotection by modulating calcineurin/NFAT1 and NFκB dependent BACE1 activity in Aβ Rajput MS; Nirmal NP; Rathore D; Dahima R Brain Res Bull; 2020 Dec; 165():97-107. PubMed ID: 32877715 [TBL] [Abstract][Full Text] [Related]
16. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice. Kimura R; Devi L; Ohno M J Neurochem; 2010 Apr; 113(1):248-61. PubMed ID: 20089133 [TBL] [Abstract][Full Text] [Related]
17. Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer's mice. Li S; Hou H; Mori T; Sawmiller D; Smith A; Tian J; Wang Y; Giunta B; Sanberg PR; Zhang S; Tan J Sci Rep; 2015 Jun; 5():11322. PubMed ID: 26091071 [TBL] [Abstract][Full Text] [Related]
18. Effects of BACE1 haploinsufficiency on APP processing and Aβ concentrations in male and female 5XFAD Alzheimer mice at different disease stages. Devi L; Ohno M Neuroscience; 2015 Oct; 307():128-37. PubMed ID: 26314636 [TBL] [Abstract][Full Text] [Related]
19. Gadd153 and NF-κB crosstalk regulates 27-hydroxycholesterol-induced increase in BACE1 and β-amyloid production in human neuroblastoma SH-SY5Y cells. Marwarha G; Raza S; Prasanthi JR; Ghribi O PLoS One; 2013; 8(8):e70773. PubMed ID: 23951005 [TBL] [Abstract][Full Text] [Related]
20. Genetic inhibition of phosphorylation of the translation initiation factor eIF2α does not block Aβ-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer's disease. Sadleir KR; Eimer WA; Kaufman RJ; Osten P; Vassar R PLoS One; 2014; 9(7):e101643. PubMed ID: 24992504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]